MoneyWorks4Me

Jubilant Pharmova informs about credit rating

27 Dec 2022 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Jubilant Pharmova has informed that India Ratings and Research has assigned Long-term issuer rating of ‘IND AA+’ Rating for the company. The instrument-wise ratings are enclosed. The Company has received the rating letter from India Ratings and Research on December 26, 2022.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..